Lisdexamfetamine - Attention Deficit Hyperactivity Disorder (ADHD) - Adults
You are here : Home > Formulary Search > Lisdexamfetamine - Attention Deficit Hyperactivity Disorder (ADHD) - Adults
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Amber
Formulations :
- Capsules
Formulary Status :
Restrictions / Comments :
Important
Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.
Patients transitioning from children's services can continue to be managed under existing arrangements
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
Documentation
Guidelines (National)
Information
PAD Profile
ChemicalSubstance :
Lisdexamfetamine
Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Adults
Group Name :
Keywords :
Attention Deficit Hyperactivity Disorder, shared care
Brand Names Include :
Elvanse
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Other Indications
Below are listed other indications that Lisdexamfetamine is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Attention Deficit Hyperactivity Disorder (ADHD) - Adults.
Committee Recommendations (1)
The PCN agreed the Amber Shared Care document below